Clinical studies have found that standardized extracts of these herbs show promise as supplementary agents for ventricular health.2-5 Other trials consistently demonstrate hawthorn’s ability to improve exercise tolerance.6,7 Its effectiveness has been demonstrated repeatedly in double-blind studies.2,4,8 Hawthorn extract shows some beneficial effects in animal and human studies, including heart health, ACE inhibition, and mild reduction in systemic vascular resistance.
Hawthorn Berry
$18.75 – $90.00
17 guests
are viewing this product
Hawthorn family have been used to promote cardiovascular health.1
| Weight | N/A |
|---|---|
| Weight | 1 lb, 5 lbs |
Supplement Facts
Serving Size 5 grams
Amount Per Serving
Organic Hawthorn berry fruit powder 5,000 mg
Other ingredients: None
Non-GMO
Dosage and Use
Take 5 grams daily, before lunch or dinner, or as recommended by a healthcare practitioner.
Warnings
- KEEP OUT OF REACH OF CHILDREN
- DO NOT EXCEED RECOMMENDED DOSE
- Do not purchase if outer seal is broken or damaged.
- When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
*These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease or health condition.
References
1. Fong HH, Bauman JL. Hawthorn. J Cardiovasc Nurs 2002 Jul;16(4):1-8.
2. Schmidt U, et al. Efficacy of the hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II. Phytomedicine 1994 1:17-24.
3. Weikl A, Assmus KD, Neukum-Schmidt A, et al. Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II). Fortschr Med 1996 Aug 30;114(24):291-6.
4. Leuchtgens H. Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study. Fortschr Med 1993 111(20- 21):352-4.
5. Tauchert M, Gildor A, Lipinski J. High- dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure. Herz 1999 24(6):465-74.
6. Busse W. Standardized Crataegus extract clinical monograph. Q Rev Nat Med 1996 189-97.
7. Weihmayr T, Ernst E. Therapeutic effectiveness of Crataegus. Fortschr Med 1996 114(1-2):27-9.
8. O’Conolly VM, et al. Treatment of cardiac performance (NYHA stages I to II) in advanced age with standardized cratae gus extract. Fortschr Med 1986 104:805-8.
Write a review
Your email address will not be published. Required fields are marked *
Reviews (0)
There are no reviews yet.